Close

Neos Therapeutics (NEOS) Says it Will Review Unsolicited Proposal from PDL BioPharma (PDLI)

October 26, 2017 10:05 AM EDT Send to a Friend
Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login